291 related articles for article (PubMed ID: 14882450)
21. [Results of BAL therapy of hepatolenticular degeneration].
WENDER M
Pol Tyg Lek; 1959 Jun; 14():1107-9. PubMed ID: 13843954
[No Abstract] [Full Text] [Related]
22. [Side-effects in BAL therapy of hepatolenticular degeneration (Westphal-Strumpell-Wilson)].
MUELLER K
Arztl Wochensch; 1960 Jan; 15():76-8. PubMed ID: 14424958
[No Abstract] [Full Text] [Related]
23. [A case of Wilson's disease of Kehrer's abdominal variety].
MINNITI G
Rass Studi Psichiatr; 1956; 45(4):756-61. PubMed ID: 13389829
[No Abstract] [Full Text] [Related]
24. Wilson's disease (hepatolenticular degeneration) and pregnancy.
Dreifuss FE; McKinney WM
JAMA; 1966 Mar; 195(11):960-2. PubMed ID: 5951974
[No Abstract] [Full Text] [Related]
25. [Therapeutic considerations on Wilson's disease].
Tavolato B; De Zanche L
G Psichiatr Neuropatol; 1966; 94(4):1085-93. PubMed ID: 5994293
[No Abstract] [Full Text] [Related]
26. [On 2 family lines with Wilson's pseudosclerosis. Clinical course and therapy, with special reference to combined therapy with BAL, penicillamine and vitamin E].
NISHI N; IIZUKA R; FUJII H; KAWAMURA K; TAKAHATA N
No To Shinkei; 1963 Jan; 15():37-48. PubMed ID: 13938756
[No Abstract] [Full Text] [Related]
27. [Treatment of Wilson's disease with 2,3-dimercaptopropanol].
MALECI O; CECOTTO C
Riv Neurol; 1953; 23(6):809-15. PubMed ID: 13168151
[No Abstract] [Full Text] [Related]
28. [Wilson's disease (hepatolenticular degeneration)].
Bickel H
Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
[No Abstract] [Full Text] [Related]
29. Treatment of hepatolenticular degeneration. (Wilson's disease).
Spellberg MA
Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
[No Abstract] [Full Text] [Related]
30. [New concepts of pathogenesis of hepatolenticular degeneration; attempt of BAL therapy; first report].
OSETOWSKA-WIECKOWSKA E
Pol Tyg Lek (Wars); 1955 Mar; 10(13):410-5. PubMed ID: 14384604
[No Abstract] [Full Text] [Related]
31. [Wilson's disease: hepatocerebral degeneration. 2. Clinical findings and therapy].
Kunath B; Biesold D
Dtsch Gesundheitsw; 1969 Jun; 24(25):1169-73. PubMed ID: 5376168
[No Abstract] [Full Text] [Related]
32. [Results of the treatment of hepatolenticular degeneration with small doses of BAL, potassium sulfide and protein-rich diets].
WENDER M
Pol Tyg Lek; 1961 Jun; 16():884-7. PubMed ID: 13784343
[No Abstract] [Full Text] [Related]
33. [LONG-TERM USE OF BAL IN WILSON'S DISEASE WITH SPECIAL REFERENCE TO THE OBSERVATION OF CHANGES IN BLOOD COPPER AND LIVER TISSUE].
TODA S; SUZUKI N; WATANABE I; WATABE T; SAKUMA T; HO K
No To Shinkei; 1964 Feb; 16():147-52. PubMed ID: 14126723
[No Abstract] [Full Text] [Related]
34. Treatment of Wilson's disease: the historical background.
Walshe JM
QJM; 1996 Jul; 89(7):553-5. PubMed ID: 8759497
[No Abstract] [Full Text] [Related]
35. Picture of the month. Wilson's disease (hepato-lenticular degeneration).
Gellis SS; Feingold M
Am J Dis Child; 1967 Jan; 113(1):177-8. PubMed ID: 6015900
[No Abstract] [Full Text] [Related]
36. [WILSON'S DISEASE].
WATANABE H
Naika; 1965 Mar; 15():435-8. PubMed ID: 14323829
[No Abstract] [Full Text] [Related]
37. The conquest of Wilson's disease.
Walshe JM
Brain; 2009 Aug; 132(Pt 8):2289-95. PubMed ID: 19596747
[No Abstract] [Full Text] [Related]
38. Chelating agents in the treatment of hepatolenticular degeneration (Wilson's disease).
BLATTNER RJ
J Pediatr; 1958 Jun; 52(6):758-61. PubMed ID: 13550045
[No Abstract] [Full Text] [Related]
39. CHEMICAL THERAPY OF WILSON'S DISEASE.
GOLDSTEIN NP; RANDALL RV; GROSS JB
J Indian Med Prof; 1965 Jul; 12():5399-402. PubMed ID: 14339732
[No Abstract] [Full Text] [Related]
40. Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
GOLDSTEIN NP; RANDALL RV; GROSS JB; ROSEVEAR JW; McGUCKIN WF
Trans Am Neurol Assoc; 1961; 86():131-4. PubMed ID: 13899919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
